In this authoritative translational review published in The American Journal of Psychiatry, leading researchers synthesize cutting-edge evidence on how cannabis use impacts adolescent neurodevelopment and behavior. Leveraging longitudinal human neuroimaging alongside rigorously controlled animal models, the article highlights compelling associations between early and frequent cannabis exposure, especially high-THC products, and disruptions in critical brain maturation processes that underlie cognition and emotional regulation.
The authors emphasize that adolescence represents a uniquely vulnerable developmental window, where cannabis exposure may potentiate risk trajectories toward psychosis, schizophrenia, anxiety, and depressive disorders — yet not all youth experience adverse outcomes. Prominent themes include the interplay of product potency, usage patterns, and individual susceptibility, and how these factors converge to influence clinical and subclinical psychopathology.
Crucially, the review points to plasticity in adolescent neural circuits, suggesting that some cannabis-related alterations may be partially reversible, bolstering the case for early intervention, targeted public education, and prevention strategies calibrated to youth risk profiles. From an East Coast Symposium perspective — grounded in translational neuroscience and clinical relevance — this article underscores both the complexity and urgency of addressing cannabis use during critical maturational periods, advancing public health dialogues and research priorities at the intersection of psychiatry, neurodevelopment, and adolescent mental health.
CLICK HERE for additional information.